Williams Donald Allen has made significant stock acquisitions in Palisade Bio, Inc., recently reporting the purchase of 20,000 shares. This move is noteworthy as it reflects the confidence of Allen, a director at Palisade Bio, in the company's growth potential within the biological products industry.
The recent filing, dated October 5, 2026, indicates that Allen acquired 10,000 shares on October 1 at a price of $1.42 per share and another 10,000 shares on October 2 at $1.46 per share. Following these transactions, Allen now holds a total of 1,590,294 shares in Palisade Bio. This level of ownership suggests a strong belief in the company's future performance.
Background
Williams Donald Allen is a director at Palisade Bio, Inc., which operates in the biological products sector, specifically focusing on products that do not include diagnostic substances. The company is incorporated in Delaware and has its business operations based in Carlsbad, California. The recent filings show Allen's ongoing engagement with the company, with multiple Form 4 submissions documenting his stock transactions.
What the Filing Says
The filing reveals that Allen purchased a total of 20,000 shares of Palisade Bio, Inc. over two days, reflecting a direct ownership stake in the company. The filing states: "transactionCode: P" indicating a purchase. Following these transactions, Allen's total shares owned increased to 1,590,294.
Impact
This acquisition may affect various stakeholders, including other shareholders of Palisade Bio, as it signals confidence in the company's direction. The biological products industry, particularly companies like Palisade Bio, may see increased interest from investors as they observe insider confidence reflected in these transactions. The market may react to this news, influencing trading activity and perceptions of the company’s future.
What's Next
The filing does not say what happens next.